🇪🇸 Spain · EU Public Tender
Suministro de los medicamentos: dabrafenib, eltrombopag, erenumab, fingolimod, lapatinib, nilotinib, omalizumab, ranibizumab, ribociclib, ruxolitinib, secukinumab y trametinib
🏛️ Gerencia de Atención Sanitaria de Melilla, Instituto Nacional de Gestión Sanitaria · 📍 Melilla
1.3M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Novartis Farmacéutica, S. A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.